Unknown

Dataset Information

0

Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives.


ABSTRACT: Pathogenic fungi are one of the main causes of hospital-related infections. Since conventional antifungals have become less effective because of the increasing fungal resistance to the standard drugs, the need for new agents is becoming urgent. Herein we report a synthesis of a series of novel N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]-benzenesulfonamide derivatives with in vitro activity against yeast-like fungi isolated from the oral cavity and respiratory tract of patients with candidiasis. These compounds were synthesized by the one-step or two-step reactions of 1-(2-alkylthiobenzensulfonyl)-2-aminoguanidines with the appropriate ortho-carbonyl benzoic acids. The biological study revealed that new derivatives have shown significant growth-inhibitory activity, superior or comparable, than those of the reference drug fluconazole. The most promising activities were observed against Candida albicans, with inhibition at least 1-3 (12.5%-37.5%) of the eight tested strains at the low MIC level of ?6.2-25 µg/mL.

SUBMITTER: Slawinski J 

PROVIDER: S-EPMC6271044 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives.

Sławiński Jarosław J   Pogorzelska Aneta A   Zołnowska Beata B   Kędzia Anna A   Ziółkowska-Klinkosz Marta M   Kwapisz Ewa E  

Molecules (Basel, Switzerland) 20140902 9


Pathogenic fungi are one of the main causes of hospital-related infections. Since conventional antifungals have become less effective because of the increasing fungal resistance to the standard drugs, the need for new agents is becoming urgent. Herein we report a synthesis of a series of novel N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]-benzenesulfonamide derivatives with in vitro activity against yeast-like fungi isolated from the oral cavity and respiratory tract of patients with candidiasis.  ...[more]

Similar Datasets

| S-EPMC10253812 | biostudies-literature
| S-EPMC3684938 | biostudies-literature
| S-EPMC2960935 | biostudies-literature
| S-EPMC3011609 | biostudies-literature
| S-EPMC3894618 | biostudies-literature
| S-EPMC2977320 | biostudies-literature
| S-EPMC3201496 | biostudies-literature
| S-EPMC2970994 | biostudies-literature
| S-EPMC2969568 | biostudies-literature
| S-EPMC3998382 | biostudies-literature